Somatostatin Receptor-Directed PET/CT for Therapeutic Decision-Making and Disease Control in Patients Affected With Small Cell Lung Cancer

Somatostatin receptor (SSTR)–targeted PET/CT is used for patients affected with small cell lung cancer (SCLC), but the clinical impact has not been elucidated yet. We aimed to determine whether SSTR PET/CT can trigger relevant therapeutic management changes in patients with SCLC and whether those mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Serfling, Sebastian E., Hartrampf, Philipp E., Zhi, Yingjun, Higuchi, Takahiro, Kosmala, Aleksander, Serfling, Julia, Schirbel, Andreas, Hörning, Anna, Buck, Andreas K., Weich, Alexander, Werner, Rudolf A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988212/
https://www.ncbi.nlm.nih.gov/pubmed/36754127
http://dx.doi.org/10.1097/RLU.0000000000004591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988212/
https://www.ncbi.nlm.nih.gov/pubmed/36754127
http://dx.doi.org/10.1097/RLU.0000000000004591

Ejemplares similares